How to Buy Rxsight Stock
Rxsight Inc
RxSight, Inc. , a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
Rxsight stock last closed at $14.20, down 1.59% from the previous day, and has decreased 72.87% in one year. It has underperformed other stocks in the Medical Devices industry by 0.54 percentage points. Rxsight stock is currently +5.19% from its 52-week low of $13.50, and -78.66% from its 52-week high of $66.54.
As of Apr 21, 2025, there are 40.49M shares of RXST outstanding. The market value of RXST is $574.97M. In the past 24 hours, 598,013 RXST shares were traded.
How to Buy Rxsight Stock
Wondering how to invest in Rxsight stock? Here's how.
- Choose where to buy Rxsight stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Rxsight stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Select your method of payment and add your info.
- Research Rxsight stock: The Rxsight ticker symbol is RXST. Is Rxsight stock a good investment? Should you buy shares of RXST? How do RXST's underlying business fundamentals look? Do top analysts think Rxsight is a good buy? Why has RXST's stock price moved recently? (Hint: Our stock analysis website can help you decide if RXST is a good stock to buy).
- Place your RXST purchase: Decide if you will purchase RXST shares at the current market price or use a limit order to buy RXST shares at a particular price.
- Monitor your RXST investment: Create a watchlist to watch your investment in Rxsight stock.
Step 1: Choose where to buy Rxsight stock
You need an online brokerage account in order to access the NASDAQ market and buy RXST shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you can buy RXST today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create your new trading account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've finished signing up on a good stock buying app, you need to deposit funds:
Watch the walkthrough below to see the process of transferring money into your new brokerage account.
Step 4: Research Rxsight stock
After you have figured out the best place to buy Rxsight stock, it's critical to evaluate their stock prior to buying, so you can wrap your head around the risk and upside.
Rxsight stock at a glance
RXST Due Diligence Score
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can view all of the due diligence checks on RXST's stock page.
What is the fair value of RXST stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RXST's fair value.
Using relative valuations measures:
- RXST may be undervalued based on its P/B ratio of 2.04x, relative to Medical Devices industry P/B ratio of 3.74x
You can access more valuation analysis on RXST's stock here.
RXST Financial Health Overview
Passed Health Checks:
- RXST has a low debt to equity ratio of 0.13.
- RXST has cash burn of 22386000. It has sufficient cash and short-term investments to cover this for at least one year.
- RXST profit margin has gone up from -54.6% to -19.6% in the past year.
- Total RXST debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the RXST balance sheet.
- There are more short-term assets than short-term liabilities on the RXST balance sheet.
- RXST has $237.97M in cash and short term investments. This is enough to cover its annual cash burn of $22.39M.
Is it a good time to buy Rxsight stock, according to analysts?
Out of 8 Wall Street analysts who monitor RXST, the consensus analyst rating on Rxsight is a Hold
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent RXST Analyst Recommendations
Craig Bijou, a top 4% analyst from Bank of America maintains RXST with a strong buy rating and lowers their RXST price target from $60.00 to $36.00, on Mar 21, 2025.
Thomas Stephan, a bottom 8% analyst from Stifel Nicolaus maintains RXST with a hold rating and lowers their RXST price target from $33.00 to $28.00, on Mar 19, 2025.
Young Li, a bottom 27% analyst from Jefferies initiates coverage on RXST with a strong buy rating and announces their RXST price target of $72.00, on Oct 29, 2024.
You can dive deeper into what analysts are saying on the Rxsight stock forecast page.
RXST Technicals
How is RXST performing as a company?
Last year, RXST revenue was $139.93M. During the last 5 year, RXST's revenue has grown by 128.61% per year. This was faster than the Medical Devices industry average of 9.8%.
Dig into RXST's earnings and revenue performance here.
Latest Insiders Trades at RXST
Over the last year, executives and large shareholders at RXST have bought more shares than they have sold.
Shelley B. Thunen, Co-President and Chief Financial Officer of RXST, was the latest RXST insider to buy. They bought $33,809.49 worth of RXST shares on Apr 14, 2025.
Research more about who owns RXST shares here.
Does RXST provide a stable income stream?
No, Rxsight doesn't provide an income stream by paying out dividends.
RXST Social Trading Data
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your RXST purchase
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific price limit, place a limit order.
Click the Open button and eToro will execute your order.
If you need more help with buying stocks on eToro, click the helpful video below:
Step 6: Monitor your RXST investment
Now that you own some shares in RXST, you'll want to stay up-to-date on your new investment.
Make a watchlist to track the most important metrics related to your RXST stock.
RXST Feed
How to Buy Stock in Rxsight
To reiterate, here are the 6 steps to buy Rxsight stock:
- Choose where to buy Rxsight stock
- Sign up for a brokerage account
- Put funds into your investment account
- Research Rxsight stock
- Place your RXST purchase
- Monitor your RXST investment
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your new investment in Rxsight, get started below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.